Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
151 studies found for:    "Down syndrome"
Show Display Options
Rank Status Study
21 Completed The Experience of Caregivers of Children With Down Syndrome
Condition: Down Syndrome
Intervention:
22 Completed Augmentative and Alternative Communication (AAC) and Lexical Gain in Children With Down Syndrome
Condition: Down Syndrome
Intervention: Behavioral: speech-language therapy with AAC intervention
23 Completed
Has Results
Efficacy and Safety of Memantine Hydrochloride in Enhancing the Cognitive Abilities of Young Adults With Down Syndrome
Condition: Down Syndrome
Interventions: Drug: Memantine;   Drug: Placebo
24 Recruiting Efficacy Assessment of Systematic Treatment With Folinic Acid and Thyroid Hormone on Psychomotor Development of Down Syndrome Young Children
Condition: Down Syndrome
Intervention: Drug: thyroid hormone and folinic acid
25 Unknown  Neuromuscular Characteristics of Individuals With Down Syndrome (DS)
Condition: Down Syndrome
Intervention: Other: muscle strength
26 Completed Motor Learning Through Virtual Reality Task in Individuals With Down Syndrome
Condition: Down Syndrome
Intervention: Behavioral: Virtual reality
27 Recruiting Comparison of Bispectral Index Values in Patients With and Without Down's Syndrome
Condition: Down Syndrome
Intervention: Device: monitoring BIS in both groups
28 Completed Correlations Phenotype / Genotype in Down Syndrome
Condition: Down Syndrome
Intervention:
29 Recruiting Investigation of the Safety of Intranasal Glulisine in Down Syndrome
Condition: Down Syndrome
Interventions: Drug: Insulin glulisine;   Drug: Saline
30 Completed A Study of RG1662 in Individuals With Down Syndrome
Condition: Down Syndrome
Interventions: Drug: Placebo;   Drug: RG1662
31 Completed Muscle Strength, Physical Work Capacity and Functional Performance in Individuals With Down Syndrome
Condition: Down Syndrome
Intervention:
32 Completed A Study of RG1662 in Adults and Adolescents With Down Syndrome (CLEMATIS)
Condition: Down Syndrome
Interventions: Drug: Placebo;   Drug: RG1662
33 Completed Assessment of Bone Density and Bone Turnover Markers in Patients With Down Syndrome and Comparison to the Ts65Dn Model
Condition: Down Syndrome
Intervention: Other: Skeletal Status Assessment of a Down Syndrome Population
34 Active, not recruiting Feasibility and Dose Tolerability of HD-tDCS in Healthy Adults and Adults With Down Syndrome
Condition: Down Syndrome
Intervention: Device: High definition transcranial direct current stimulation
35 Recruiting Safety, Tolerability and Immunogenicity of ACI-24 Vaccine in Adults With Down Syndrome
Condition: Down Syndrome
Interventions: Biological: ACI-24 low dose;   Biological: ACI-24 high dose;   Biological: Placebo
36 Active, not recruiting A Study of RG1662 in Down Syndrome Among Children 6 to 11 Years of Age
Condition: Down Syndrome
Interventions: Drug: Placebo;   Drug: RG1662
37 Completed Effects of Whole-body Vibration Training on Body Composition in Adolescents With and Without Down Syndrome
Condition: Down Syndrome
Intervention: Device: Whole-body vibration training (Power Plate®) on bone mass and bone metabolism in adolescents with and without Down syndrome.
38 Completed Non-drug Study to Assess the Suitability of Assessment Scales in Japanese Individuals With Down Syndrome Aged 6-30
Condition: Down Syndrome
Intervention:
39 Completed A Screening Protocol to Assess Adults and Adolescents With Down Syndrome for Eligibility For Upcoming Study of RG1662 (Study BP27832)
Condition: Down Syndrome
Intervention:
40 Completed Non-drug Study to Evaluate the Suitability of Neurocognitive Tests and Functioning Scales for the Measurement of Cognitive and Functioning Changes in Children With Down Syndrome
Condition: Down Syndrome
Intervention: Other: No Intervention

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.